Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab versus standard second-line chemotherapy in MSI metastatic colorectal cancer
2016-004575-49Phase 2Active
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jul 2017
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in colorectal cancer (CRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jul 2017; status: active.
02
Drugs
avelumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2016-004575-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004575-49.